+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gardasil"

From
Cervical Cancer Vaccine Global Market Report 2024 - Product Thumbnail Image

Cervical Cancer Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Human Papillomavirus (HPV) Vaccine Global Market Report 2024 - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Cancer Vaccines Global Market Report 2024 - Product Thumbnail Image

Cancer Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Cancer Vaccines: Analytical Tool - Product Thumbnail Image

Cancer Vaccines: Analytical Tool

  • Report
  • April 2024
  • Global
From
Global Cancer Vaccine Market & Clinical Trials Outlook 2028 - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trials Outlook 2028

  • Report
  • July 2022
  • 600 Pages
  • Global
From
From
Cancer Vaccines Market, Pipeline Analysis Report 2020 - Product Thumbnail Image

Cancer Vaccines Market, Pipeline Analysis Report 2020

  • Report
  • June 2020
  • 115 Pages
  • Global
From
From
Cancer Vaccines - Competitive landscape, 2023 - Product Thumbnail Image

Cancer Vaccines - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
From
Disease Analysis: Human Papillomavirus (HPV) Vaccines - Product Thumbnail Image

Disease Analysis: Human Papillomavirus (HPV) Vaccines

  • Report
  • June 2021
  • 32 Pages
  • Global
Global Cancer Vaccine Market & Clinical Trial Insight 2025 - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trial Insight 2025

  • Clinical Trials
  • September 2018
  • 700 Pages
  • Global
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Gardasil is a cancer vaccine developed by Merck & Co. and approved by the U.S. Food and Drug Administration (FDA) in 2006. It is used to prevent certain types of cancers caused by the human papillomavirus (HPV). Gardasil is the only HPV vaccine available in the United States and is recommended for both boys and girls aged 9 to 26. The vaccine is administered in three doses over a six-month period. Gardasil is part of a larger market of cancer vaccines, which are designed to prevent or treat certain types of cancer. These vaccines are typically made from weakened or killed versions of the virus that causes the cancer, and are administered to individuals to help their bodies build immunity to the virus. Cancer vaccines are used to prevent or treat a variety of cancers, including cervical, head and neck, and liver cancers. The Gardasil market is highly competitive, with several companies offering similar products. These include GlaxoSmithKline, Sanofi Pasteur, and Pfizer. Other companies, such as CSL Limited and Merck KGaA, also offer HPV vaccines. Show Less Read more